Showing 1 - 12 results of 12 for search 'Lucija Kuna', query time: 0.48s
Refine Results
-
1
-
2
Glycosylation Alterations in Cancer Cells, Prognostic Value of Glycan Biomarkers and Their Potential as Novel Therapeutic Targets in Breast Cancer by Luka Peric, Sonja Vukadin, Ana Petrovic, Lucija Kuna, Nora Puseljic, Renata Sikora, Karla Rozac, Aleksandar Vcev, Martina Smolic
Published 2022-12-01
Article -
3
Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy by Vjera Ninčević, Milorad Zjalić, Tea Omanović Kolarić, Martina Smolić, Tomislav Kizivat, Lucija Kuna, Aleksandar Včev, Ashraf Tabll, Ines Bilić Ćurčić
Published 2022-02-01
Article -
4
Pretreatment of Garlic Oil Extracts Hampers Epithelial Damage in Cell Culture Model of Peptic Ulcer Disease by Lucija Kuna, Milorad Zjalic, Tomislav Kizivat, Hrvoje Roguljic, Vjera Nincevic, Tea Omanovic Kolaric, Catherine H. Wu, Aleksandar Vcev, Martina Smolic, Robert Smolic
Published 2022-01-01
Article -
5
Antimicrobial Resistance and Antimicrobial Stewardship: Before, during and after the COVID-19 Pandemic by Omar Khaznadar, Farah Khaznadar, Ana Petrovic, Lucija Kuna, Ana Loncar, Tea Omanovic Kolaric, Vjera Mihaljevic, Ashraf A. Tabll, Robert Smolic, Martina Smolic
Published 2023-05-01
Article -
6
Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced St... by Tea Omanovic Kolaric, Tomislav Kizivat, Vjera Mihaljevic, Milorad Zjalic, Ines Bilic-Curcic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, George Y. Wu, Martina Smolic
Published 2022-08-01
Article -
7
Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy by Vjera Mihaljević, Milorad Zjalić, Tomislav Kizivat, Tea Omanović Kolarić, Martina Smolić, Edi Rođak, Marina Čović, Lucija Kuna, Robert Smolić, Aleksandar Včev, Ines Bilić Ćurčić
Published 2022-11-01
Article -
8
Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy by Farah Khaznadar, Ana Petrovic, Omar Khaznadar, Hrvoje Roguljic, Kristina Bojanic, Lucija Kuna Roguljic, Stjepan Siber, Robert Smolic, Ines Bilic-Curcic, George Y. Wu, Martina Smolic
Published 2023-10-01
Article -
9
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD by Ana Petrovic, Dunja Igrec, Karla Rozac, Kristina Bojanic, Lucija Kuna, Tea Omanovic Kolaric, Vjera Mihaljevic, Renata Sikora, Robert Smolic, Marija Glasnovic, George Y. Wu, Martina Smolic
Published 2023-05-01
Article -
10
Mechanistic-Based Classification of Endocytosis-Related Inhibitors: Does It Aid in Assigning Drugs against SARS-CoV-2? by Mohamed Hessien, Thoria Donia, Ashraf A. Tabll, Eiman Adly, Tawfeek H. Abdelhafez, Amany Attia, Samar Sami Alkafaas, Lucija Kuna, Marija Glasnovic, Vesna Cosic, Robert Smolic, Martina Smolic
Published 2023-04-01
Article -
11
Preclinical Models and Promising Pharmacotherapeutic Strategies in Liver Fibrosis: An Update by Tea Omanovic Kolaric, Lucija Kuna, Marina Covic, Hrvoje Roguljic, Anita Matic, Renata Sikora, Marija Hefer, Ana Petrovic, Vjera Mihaljevic, Robert Smolic, Ines Bilic-Curcic, Aleksandar Vcev, Martina Smolic
Published 2023-05-01
Article -
12
Changes in Dickkopf-1, but Not Sclerostin, in Gingival Crevicular Fluid Are Associated with Peroral Statin Treatment in Patients with Periodontitis by Kristina Duspara, Renata Sikora, Ana Petrovic, Lucija Kuna Roguljic, Anita Matic, Kristina Kralik, Hrvoje Roguljic, Tomislav Kizivat, Mirjana Duspara, Dunja Igrec, Kristina Bojanic, Robert Smolic, Aleksandar Vcev, Magdalena Wyszyńska, George Y. Wu, Martina Smolic
Published 2024-03-01
Article